SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
-7.48%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$484M
AUM Growth
+$484M
(+4.2%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
15.95%
Top 10 Holdings %
Top 10 Hldgs %
73.12%
Holding
58
New
4
Increased
1
Reduced
4
Closed
2
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$70.8M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$6.87M |
| 3 |
ATYR
aTyr Pharma
ATYR
|
$3.68M |
| 4 |
INZY
Inozyme Pharma
INZY
|
$2.89M |
| 5 |
Leap Therapeutics
LPTX
|
$288K |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$2.95M |
| 2 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$2.16M |
| 3 |
Arcellx
ACLX
|
$1.47M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$578K |
| 5 |
BCEL
Atreca, Inc. Class A Common Stock
BCEL
|
$153K |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Surrozen
SRZN
$113M
| $181K | 0.04% |
300,000
| – | – |
|
52
Novavax
NVAX
$1.23B
| $147K | 0.03% |
21,244
| – | – |
|
|
KRON
53
DELISTED
Kronos Bio
KRON
| $114K | 0.02% |
78,131
| – | – |
|
|
NGM
54
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $55.8K | 0.01% |
13,669
| – | – |
|
55
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
| $16K | ﹤0.01% |
133,333
| – | – |
|
|
56
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $10K | ﹤0.01% |
99,999
| – | – |
|
|
SWTX
57
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-22,204
| Closed | -$578K |
|
|
ALBO
58
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| – | – |
-100,000
| Closed | -$2.16M |
|